Упрощенная HTML-версия
112
responders / H. Matsumoto, I. Noji, Y. Akimoto, A. Fujii // J. Oral Sci. – 2001.
– Vol. 43, _ 4. – P. 261-268.
107.
Effects of combined oral treatments with cyclosporine A and nifedipine
or diltiazem on drug-induced gingival overgrowth in rats / I. Morisaki, N.
Fukui, Y. Fujimori et al. // J. Periodontol. – 2000. – Vol. 71, _ 3. – P. 438-
443.
108.
Regression of nifedipine-induced gingival hyperplasia following switch
to a same class calcium channel blocker, isradipine / P. Westbrook, E.M.
Bednarczyk, M. Carlson et al. // J.Periodontol. – 1997. – Vol. 68, _ 7. – P.
645-650.
109.
Pathogenesis of drug-induced gingival overgrowth. A review of studies
in the rat model / S. Nishikawa, T. Nagata, I. Morisaki et al. // J. Periodontol. –
1996. – Vol. 67, _ 5. – P. 463-471.
110.
Effect of calcium-channel blockers on cell proliferation, DNA synthesis
and collagen synthesis of cultured gingival fibroblasts derived from human
nifedipine responders and non-responders / A. Fujii, H. Matsumoto, S. Nakao,
et al. // Arch. Oral Biol. – 1994. – Vol. 39, _ 2. – P. 99-104.
111.
Prevalence and risk of gingival enlargement in patients treated with
nifedipine / J. Miranda, L. Brunet, P. Roset et al. // J. Periodontol. - 2001. –
Vol. 72, _5. – P. 605-611.
112.
Clinical assessment of periodontal conditions in patients treated with
nifedipine / C. Neumann, B. Willershausen-Zonnchen, C. Klug, H. Darius //
Eur. J. Med. Res. – 1996. – Vol. 1, _ 6. – P. 273-279.
113.
Immunosuppressant therapy and bone loss in ligature-induced
periodontitis--a study in rats / P.F. Goncalves, R. Nogueira Filho Gda, E.A.
Sallum, et al. // Perqui Odontol. Bras. – 2003. – Vol. 17, _ 1. – P. 46-50.
114.
Dental changes in patients treated with calcium antagonists / S.Ivanova,
A. Kiselova-Ianeva, L. Dimitrov, N. Stanchev // Vutr. Boles. – 1999. – Vol.
31, _ 4. – P. 41-44.